Not exact matches
A one - time intravenous infusion of the high dose of
gene therapy extended the survival of patients with spinal muscular atrophy type 1 (SMA1) in a Phase 1 clinical
trial, according to a study
published in the New England Journal of Medicine.
As a new generation of
gene therapy clinical
trials shows promise to cure or halt the progression of several rare diseases, the time has come to explore ways to pay for the cutting edge treatments, a pediatric hematologist - oncologist from Dana - Farber / Boston Children's Cancer and Blood Disorders Center argues in a commentary
published by the journal Science.
A «cure» for haemophilia is one step closer, following results
published in the New England Journal of Medcine of a groundbreaking
gene therapy trial led by the NHS in London.
The research, part of a phase I clinical
trial to test the safety of the treatment, was
published as a letter to the editor in The New England Journal of Medicine earlier this week and will be in the September issue of Human
Gene Therapy.
Spark Therapeutics»
gene therapy for patients with haemophilia has seen some early success in clinical
trials, according to a report
published yesterday.
George Church, a Harvard Medical School geneticist who
published one of the early papers on the use of CRISPR on mammalian cells, pointed out that people in his field have been doing genetic modification for decades, and said there are already 2,000
gene therapy trials underway, none of which use CRISPR.
The results from the first human
trials for a
gene therapy to treat haemophilia A have just been
published.
Lung Cancer Breakthrough A study
published in the September, 1998 issue of Nature Medicine concerned a preliminary
trial using
gene therapy to treat lung cancer.